N-acetyl-L-leucine: a promising treatment option for traumatic brain injury

被引：0
|
作者：
Chinmoy Sarkar [1 ]
Marta M.Lipinski [1 ,2 ]
机构：
[1] Shock,Trauma and Anesthesiology Research (STAR)Center,Department of Anesthesiology,University of Maryland School of Medicine
[2] Department of Anatomy and Neurobiology,University of Maryland School of Medicine
来源：
NeuralRegenerationResearch | 2022年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R651.15 [];
学科分类号：
1002 ; 100210 ;
摘要：
Traumatic brain injury (TBI) is a mechanical injury to the brain,which can be sustained due to falls,accidents,contact sports or in combat situation.It is a serious health problem-affecting people of all ages worldwide.As per the recent epidemiological study,more than 55 million people suffer from TBI annually (GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators,
引用
收藏
页码：1957 / 1958
页数：2
相关论文
共 50 条
  • [31] Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine
    Hoffer, Barry J.
    Pick, Chaim G.
    Hoffer, Michael E.
    Becker, Robert E.
    Chiang, Yung-Hsiao
    Greig, Nigel H.
    JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24
  • [32] Endocannabinoids: A Promising Impact for Traumatic Brain Injury
    Schurman, Lesley D.
    Lichtman, Aron H.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [33] Decompressive craniectomy is an efficient treatment option for traumatic brain injury: Our experience
    Bunc, Gorazd
    Ravnik, Janez
    Klobucar, Robert
    Velnar, Tomaz
    BRAIN INJURY, 2014, 28 (5-6) : 608 - 608
  • [34] Normobaric hyperoxia - A further treatment option following traumatic brain injury? Reply
    Nortje, Jurgens
    Coles, Jonathan P.
    Menon, David K.
    CRITICAL CARE MEDICINE, 2008, 36 (05) : 1698 - 1698
  • [35] Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-pick disease type C
    Strupp, Michael
    Bremova-Ertl, Tatiana
    Fields, Taylor
    Factor, Mallory
    Martakis, Kyriakos
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [36] Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat Brain
    Scafidi, Susanna
    Racz, Jennifer
    Hazelton, Julie
    McKenna, Mary C.
    Fiskum, Gary
    DEVELOPMENTAL NEUROSCIENCE, 2010, 32 (5-6) : 480 - 487
  • [37] N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
    T Fields
    T M. Bremova
    I Billington
    GC Churchill
    W Evans
    C Fields
    A Galione
    R Kay
    T Mathieson
    K Martakis
    M Patterson
    F Platt
    M Factor
    M Strupp
    Trials, 24
  • [38] Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
    Fields, Taylor
    Bremova-Ertl, Tatiana
    Ramaswami, Uma
    Brands, Marion
    Gautschi, Matthias
    Gissen, Paul
    Hahn, Andreas
    Jones, Simon
    Kolnikova, Miriam
    Arash-Karps, Laila
    Mengel, Eugen
    Park, Julien
    Reichmannova, Stella
    Schneider, Susanne
    Sivananthan, Siyamini
    Walterfang, Mark
    Wibawa, Pierre
    Strupp, Michael
    Martakis, Kyriakos
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [39] AQUEOUS-SOLUTIONS CONTAINING AMINO-ACIDS AND PEPTIDES .11. ENTHALPY OF DILUTION OF SINGLE AND BINARY SOLUTE SOLUTIONS OF N-ACETYL-GLYCINE AMIDE, N-ACETYL-L-ALANINE AMIDE, N-ACETYL-L-VALINE AMIDE AND N-ACETYL-L-LEUCINE AMIDE AT 298.15-K
    BLACKBURN, GM
    LILLEY, TH
    WALMSLEY, E
    JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1980, 76 : 915 - 922
  • [40] Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial
    Beyraghi-Tousi, Mehran
    Sahebkar, Amirhosein
    Houra, Mahsa
    Sarvghadi, Pooria
    Jamialahmadi, Tannaz
    Bagheri, Reza
    Tavallaie, Shima
    Gumpricht, Eric
    Saberi-Karimian, Maryam
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 50 : 57 - 63
12345